A Web-Based Dyadic Intervention for Colorectal Cancer

Last updated: December 5, 2024
Sponsor: Emory University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Cancer/tumors

Carcinoma

Colorectal Cancer

Treatment

Interview

Electronic Health Record Review

Internet-Based Intervention

Clinical Study ID

NCT05663203
STUDY00004750
2022RE03
EU5733-22
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This clinical trial studies how well a web-based dyadic intervention works to manage psychoneurological symptoms for patients with colorectal cancer and their caregivers. Patients with colorectal cancer receiving chemotherapy experience severe and distressing psychoneurological symptoms that include fatigue, depression, sleep disturbance, pain, and cognitive dysfunction. When these co-occurring symptoms are undertreated, they negatively affect functional status, survival rates, and quality of life of patients as well as decrease health outcomes of their family caregiver. A critical need exists to develop an effective and novel intervention that focuses on patients with colorectal cancer receiving chemotherapy and their caregivers. A web-based dyadic intervention holds great promise to reduce psychoneurological symptoms burden and improve quality of life for patients with colorectal cancer receiving chemotherapy and advance intervention development and implementation in cancer supportive care and health equity.

Eligibility Criteria

Inclusion

INCLUSION CRITERIA

Patients:

  • Age >= 18 years

  • Diagnosed with colorectal cancer

  • Life expectancy > 12 months

  • Receiving active chemotherapy

  • Self-reported at least two psychoneurological symptoms (based on the symptom measures' cutoff scores)

  • Identified primary caregiver (i.e., family members or significant others identified by the patients as their primary source of emotional and physical support)

  • Access to the Internet

  • Fluent in English

Caregivers:

  • Age >= 18 years

  • Primary caregiver

  • Access to the Internet

  • Fluent in English

EXCLUSION CRITERIA

Patients:

• Karnofsky Performance Scale < 50

Caregivers:

• Have severe diseases (e.g., cancer, heart disease)

Study Design

Total Participants: 56
Treatment Group(s): 4
Primary Treatment: Interview
Phase:
Study Start date:
May 01, 2023
Estimated Completion Date:
October 01, 2026

Study Description

PRIMARY OBJECTIVES:

I. To develop a web-based dyadic intervention for patients with colorectal cancer receiving chemotherapy and their caregivers (CRCweb).

Ia. Determine tailored contents by identifying needs and supports for a web-based dyadic intervention using interviews with patient-caregiver dyads (n=8); Ib. Develop a prototype of a web-based dyadic intervention program (CRCweb); Ic. Test the usability (e.g., design, navigation, structure, language) of CRCweb prototype using interviews with 4 dyads (in Aim Ia).

II. Evaluate the feasibility and acceptability of CRCweb for patients with colorectal cancer receiving chemotherapy and their caregivers in 20 dyads in a pilot clinical trial.

III. Evaluate the preliminary effects of CRCweb on the primary outcome (i.e., attrition, adherence, acceptability, fatigue, depression, sleep disturbance, pain, and cognitive dysfunction) and secondary outcomes (i.e., quality of life) for patients with colorectal cancer receiving chemotherapy and their caregivers in 20 dyads in a pilot clinical trial.

OUTLINE:

Patients and caregivers attend a CRCweb intervention over 8 weeks. Patients and caregivers complete interviews and surveys throughout the trial.

Connect with a study center

  • Emory University/Winship Cancer Institute

    Atlanta, Georgia 30322
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.